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Abstract
Objectives—This study reports on the synthesis, materials characterization, antimicrobial 
capacity, and cytocompatibility of novel ZnO-loaded membranes for guided tissue/bone 
regeneration (GTR/GBR).
Methods—Poly(ε-caprolactone) (PCL) and PCL/gelatin (PCL/GEL) were dissolved in 
hexafluoropropanol and loaded with ZnO at distinct concentrations: 0 (control), 5, 15, and 30 wt.
%. Electrospinning was performed using optimized parameters and the fibres were characterized 
via scanning and transmission electron microscopies (SEM/TEM), energy dispersive X-ray 
spectroscopy (EDS), Fourier transform infrared spectroscopy (FTIR), contact angle (CA), 
mechanical testing, antimicrobial activity against periodontopathogens, and cytotoxicity test using 
human dental pulp stem cells (hDPSCs). Data were analyzed using ANOVA and Tukey (α=5%).
Results—ZnO nanoparticles were successfully incorporated into the overall submicron fibres, 
which showed fairly good morphology and microstructure. Upon ZnO nanoparticles’ 
incorporation, the PCL and PCL/GEL fibres became thicker and thinner, respectively. All GEL-
containing membranes showed lower CA than the PCL-based membranes, which were highly 
hydrophobic. Overall, the mechanical properties of the membranes were reduced upon ZnO 
incorporation, except for PCL-based membranes containing ZnO at the 30 wt.% concentration. 
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The presence of GEL enhanced the stretching ability of membranes under wet conditions. All 
ZnO-containing membranes displayed antibacterial activity against the bacteria tested, which was 
generally more pronounced with increased ZnO content. All membranes synthesized in this study 
demonstrated satisfactory cytocompatibility, although the presence of 30 wt.% ZnO led to 
decreased viability.
Significance—Collectively, this study suggests that PCL- and PCL/GEL-based membranes 
containing a low content of ZnO nanoparticles can potentially function as a biologically safe 
antimicrobial GTR/GBR membrane.
Graphical Abstract
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1. Introduction
Periodontitis is a very prevalent (ca. ~ 50% of the adult population) and aggressive dental 
pathology affecting both the gingiva and anchoring tissues of the tooth [1]. It is a bacterial-
mediated inflammatory process, and if not treated, it may progressively destroy periodontal 
tissues, eventually resulting in tooth loss [2]. A recent systematic review confirmed that 
severe periodontitis has increased in the past two decades, and a predictable increasing 
burden of the disease can be expected, since life expectancy among the world population is 
continuously growing [3].
The traditional clinical treatment of periodontitis consists of surgical procedures and 
mechanical debridement (i.e. scaling and root planing), which allows healing of periodontal 
pockets/defects [4, 5]. Moreover, systemic and/or local antibiotic therapy may also be 
indicated in order to combat the infection or re-colonization of periodontopathogens [4–6]. 
Nonetheless, depending on the size of the pocket/inflamed site, the complete regeneration of 
periodontal tissues remains a difficult clinical task [4]. In this way, regenerative approaches, 
such as the use of bioresorbable or non-resorbable barrier membranes employed in so-called 
guided tissue/bone regeneration (GTR/GBR) strategies, as well as emerging technologies 
(e.g. cell-based and gene therapies, the use of bone anabolics, and laser treatments, among 
others) have been investigated in terms of their clinical potential in periodontal tissue 
regeneration [4, 7, 8]. Among the aforementioned approaches, GTR/GBR membranes 
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present the unique characteristic of resembling the extracellular matrix (ECM), thus 
facilitating cell adhesion, proliferation, and the differentiation of new tissues [4]. 
Furthermore, GTR/GBR membranes can be synthesized using a variety of natural and/or 
synthetic polymers, and depending on processing conditions, bioactive (e.g. antimicrobials) 
fibres on the nano- and micro-scale range can be fabricated [4, 6, 9–12].
Despite the fairly significant clinical success achieved with the use of membranes in 
GTR/GBR strategies, tissue regeneration is strongly dependent on the absence of infection, 
and therefore, the proper maintenance of a bacteria-free environment [4]. To that end, 
several controlled-release systems, such as Atridox® (doxycycline-based) and PerioChip® 
(chlorhexidine-based), have been thoroughly used to locally deliver antimicrobial agents to 
the periodontal pocket, resulting in positive clinical effects [13, 14]. More recently, 
antimicrobial agents have been incorporated into GTR/GBR membranes, endowing to them 
antibacterial activity [6, 15]. Notwithstanding, it is well recognized that antibiotics may 
produce some important side-effects, mainly those related to bacterial strain resistance, 
which is a current global concern, since bacteria are becoming resistant to several antibiotic 
therapies [4, 6]. Therefore, the development of biomaterials for GTR/GBR applications 
based on alternative antibacterial agents rather than antibiotics is paramount to translate 
safer regenerative technologies into clinical practice.
Inorganic ions and metallic oxides have extensively demonstrated antibacterial properties 
[16–19]. Silver is the most effective antibacterial metal at low concentrations and against 
both gram-positive (G+) and gram-negative (G−) bacteria. Meanwhile, several other metal 
oxides (e.g. copper, magnesium, calcium, titanium, and zinc) have also displayed important 
antibacterial activity against a wide variety of microorganisms. Zinc oxide (ZnO), for 
example, is one of the few zinc-based compounds listed as being generally recognized as a 
safe (GRAS) material by the Food and Drug Administration (FDA) [20]. Even though the 
mechanism of action is still vaguely understood, ZnO has been successfully used as an 
antibacterial agent in food packaging [21], restorative dental materials [22], wound dressings 
[23], and in tissue engineering applications [24]. Indeed, electrospun polymer-based 
scaffolds/membranes loaded with ZnO have recently displayed not only antibacterial 
properties [25], but also enhanced cell proliferation/wound healing [26]. It is also important 
to note that the antibacterial activity of these ZnO-loaded membranes was found to be dose-
dependent (≥ 5 wt.%) [25]. Nonetheless, the earlier study tested the ZnO-scaffolds only on 
Staphylococcus aureus (G+) and Escherichia coli (G−), thus further highlighting the need to 
investigate their potential against periodontopathogens based on their application as 
GTR/GBR membranes.
It is well-established that degradability is one of the most important aspects involved in the 
clinical success of bioresorbable GTR/GBR membranes [4]. Indeed, it is expected that the 
membrane would be completely resorbed after treatment is completed, thus eliminating an 
additional surgical procedure for its removal from the regenerated site [4]. The degradability 
rate of GTR/GBR membranes strongly depends on the type of polymer system used. Poly(ε-
caprolactone) (PCL) is a synthetic polymer with known degradability and hydrophobic 
characteristics [27], and considering the latter property influences the former, with highly 
hydrophobic systems displaying lower degradability, PCL usually presents a moderate 
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degradation rate. Recent research has utilized the strategy of blending natural polymers, 
such as collagen or gelatin, with PCL to grant enhanced degradability and hydrophilicity 
[28–30], as well as better cell-membrane response [31].
In this study, we tested the influence of ZnO nanoparticles and gelatin on the physico-
chemical and mechanical properties of PCL-based electrospun membranes. Furthermore, we 
report for the first time on the antibacterial activity and cytocompatibility of these 
membranes’ targeting a specific application in periodontal tissue regeneration by careful 
antimicrobial and cell compatibility evaluations against periodontopathogens and dental 
pulp stem cells, respectively.
2. Materials and methods
2.1. Materials
Poly(ε-caprolactone) pellets (PCL, Mw = 80,000), gelatine type B from bovine skin (~225 
bloom, Mw = 50,000), 1,1,1,3,3,3-hexafluoro-2-propanol (HFP), and zinc oxide 
nanoparticles (ZnO, < 100 nm particle size) were all purchased from Sigma-Aldrich (St. 
Louis, MO, USA) and used as-received. Phosphate-buffered saline solution (PBS, 1%) was 
prepared by mixing PBS tablets (MP Biomedicals, Santa Ana, CA, USA) and distilled 
water. The plastic syringes (5 mL) and 27G dispensing needles were obtained from Becton, 
Dickson and Company (Franklin Lakes, NJ, USA) and CML Supply (Lexington, KY, USA), 
respectively.
2.2. Synthesis of PCL and PCL/Gelatin membranes loaded with ZnO nanoparticles
The electrospinning system used in this work consisted of a high-voltage source 
(ES50P-10W/DAM, Gamma High-Voltage Research Inc., Ormond Beach, FL, USA), a 
syringe pump (Legato 200, KD Scientific Apparatus, Holliston, MA, USA), and a grounded 
stainless steel collecting drum connected to a high-speed mechanical stirrer (BDC6015, 
Caframo, Wiarton, ON, Canada), and was described in detail elsewhere [6, 32, 33]. 
Processing parameters, including solution concentration, field strength, and flow rate were 
optimized for the distinct polymer systems to obtain defect-free fibrous membranes. Two 
stock polymer solutions were prepared in HFP; namely, pure PCL and a PCL/gelatin blend 
(PCL/GEL, ratio of 1:1, w/w). Briefly, the polymers were dissolved in HFP to produce 10 
wt.% (100 mg mL−1) and were stirred overnight. Next, ZnO nanoparticles were added at 
different concentrations (0, 5, 15, and 30 wt.%, relative to the total polymer weight); the 
mixtures were stirred for 24 h and then sonicated for 90 minutes before electrospinning to 
improve nanoparticle dispersion [7]. Each solution was then loaded into the plastic syringe 
fitted with the 27G metallic blunt-tip and electrospun using the following parameters: 
rotating mandrel (120 rpm of speed), fixed spinning distance of 18 cm, flow rate of 1.5 
mL/h, and different electric voltages, depending on the solution, as determined by an 
optimization process that involved experiments conducted on each variable. The obtained 
mats (hereafter referred to as membranes), i.e. pure PCL, PCL/GEL, and the ones containing 
ZnO nanoparticles, were collected at room temperature (RT) and then dried under vacuum 
for at least 48 h to complete removal of any remaining solvent [7, 32].
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2.3. Morphological (SEM/TEM) and Chemical (EDS/FTIR) Characterizations of the fibres
The electrospun membranes were observed under a field-emission scanning electron 
microscope (FE-SEM, Model JSM-6701F, JEOL, Tokyo, Japan) to evaluate the morphology 
and overall fibre architecture. In brief, samples taken from the different electrospun 
membranes were mounted on an Al stub and sputter-coated with Au-Pd prior to imaging. 
Image J software (National Institutes of Health, Bethesda, MD, USA) was used to calculate 
the diameter of 50 single-fibres per image obtained from the FE-SEM analyses (3 images/
group) at the same magnification (5000×); the fibre diameter was then averaged and 
reported as mean±SD [7, 32]. Energy dispersive X-ray spectroscopy (EDX) was performed 
under FE-SEM to semi-quantitatively analyse the chemical composition of the fibres. 
Transmission electron microscopy (TEM, Model JEM-2010, JEOL) was also carried out to 
investigate the ZnO nanoparticles’ incorporation into the polymer fibres. Fourier transform 
infrared spectroscopy (FTIR) was done in the attenuated total reflection mode for the PCL, 
PCL/GEL, and membranes containing ZnO nanoparticles (ATR/FTIR-4100, JASCO, 
Easton, MD, USA), over the range of 700–4,000 cm−1 at a resolution of 4 cm−1 to 
investigate the chemical characteristics of the membranes and ZnO incorporation [7, 32].
2.4. Contact angle (CA)
The PCL and PCL/GEL solutions loaded or not with the distinct concentration of ZnO were 
electrospun into fibres using the aforementioned electrospinning parameters over 
microscope glass coverslips (Fisherbrand, Fisher Scientific, Loughborough, UK) mounted 
on the rotating mandrel (n=10). Next, the surface CA of the membranes was measured using 
a goniometer (Model PG-2, Gardco, Pompano Beach, FL, USA) by dropping three 
consecutive drops of distilled water (~ 5 µL) per sample. The measured angles were then 
averaged.
2.5. Mechanical properties
The mechanical properties (i.e. tensile strength, Young’s modulus, and elongation at break) 
of all the synthesized electrospun membranes were evaluated by uni-axial tensile testing 
(expert 5601, ADMET, Norwood, MA, USA) [32]. Rectangular samples (15 mm × 3 mm) 
were tested (n=4) under both dry (immediate testing without storage) or wet (tested after 
storage in PBS solution for 24 h) conditions at a crosshead speed of 1 mm min−1. The 
specimen thickness was determined by measuring with calipers at three locations. 
Mechanical data were obtained from the stress-strain curves of each sample and expressed in 
MPa. The results are reported as mean ± standard deviation (SD).
2.6. Antimicrobial activity
The antibacterial activity of the processed fibrous membranes was evaluated against known 
periodontopathogens, i.e. Porphyromonas gingivalis (Pg) (ATCC 33277) and 
Fusobacterium nucleatum (Fn) (ATCC 25586) using agar diffusion assays (n=3/group/
bacteria) [33]. Bacteria were cultivated in Brain Heart Infusion (BHI) broth supplemented 
with 5 g yeast extract/L and 5% v/v vitamin K+ hemin (BHI-YE; Becton, Dickinson and 
Company) at 37°C in an anaerobic GasPak jar for 24 h [33]. Before testing, the minimum 
inhibitory concentration (MIC) of ZnO was determined using suspensions of ZnO 
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nanoparticles in PBS at the following concentrations: 100, 250, 500, 1,000, 2,500, 5,000, 
and 10,000 µg/mL. In brief, 10 µL of each suspension was dropped on cultured blood agar 
plates containing the bacterial lawns, and the inhibition zones (in mm) were measured after 
5 days of incubation [33]. For the antibacterial activity of the membranes, disk-shaped 
samples (5-mm in diameter) were prepared and sterilized through ultraviolet (UV) 
irradiation for 1 h (30 min each side), before placing on the cultured blood agar plates as 
previously indicated [33, 34]. The inhibition zone (in mm) of each sample was measured 
after 5 days of incubation.
2.7. Cytotoxicity test
The guidelines provided by the International Standards Organization/ISO [35] were 
followed in order to detect toxicity levels of the electrospun membranes [34]. Human dental 
pulp stem cells (hDPSCs, AllCells LLC., Alameda, CA, USA) obtained from permanent 
third molars were cultured in low glucose Dulbecco’s Modified Eagle’s Medium (DMEM, 
GIBCO, Invitrogen, Grand Island, NY, USA) supplemented with 10% FBS (Hyclone 
Laboratories Inc., Logan, UT, USA) and 1% penicillin-streptomycin (Sigma) in a humidifier 
incubator at 37°C, with 5% CO2 [34]. All the processed membranes were carefully cut into 
squares (15 × 15 mm2) and sterilized under UV light (30 min each side) and by soaking in 
70% ethanol for 30 min, followed by washing (5 min) twice in sterile PBS before testing 
[34]. Next, sterile samples (surface ratio = 1 cm2/mL of medium) were incubated in DMEM 
for 48 h at 37°C under a 5% CO2 humidified atmosphere in order to produce extracts from 
each membrane [34]. Extracts of sterile ultra-high molecular weight polyethylene 
(UHMWPE) were similarly obtained (negative control). Supernatants were then filtered 
through a membrane (Millipore®), and serial dilutions (100, 50, 25, 12.5, and 6.25 vol.%) 
were prepared from the extracts [34, 36]. Dilutions were also performed for the positive 
control (i.e. 0.3 vol.% phenol solution) [34, 36]. hDPSCs at passage 9 were seeded at a 
density of 3×103/well and allowed to adhere in the wells of 96-well tissue culture microtiter 
plates. The media was replaced after 4 h by the corresponding extract concentrations, and 
negative and positive controls, which were dispensed into each well (100 µL) [34]. Control 
columns of four wells were prepared with a medium without cells (blank), and a medium 
with cells but without the extract (100% survival) [34–36]. The microplate was then 
incubated again and after 48 h, 20 µL of CellTiter 96 AQueous One Solution Reagent 
(Promega Corporation, Madison, WI, USA) was added to the test wells and allowed to react 
for 2 h at 37°C in humidified 5% CO2 atmosphere. Incorporated dye was measured by 
reading the absorbance at 490 nm in a microplate reader against a blank column [34–36].
2.8. Statistical analysis
The obtained data were statistically analysed (SigmaPlot version 12, Systat Software Inc., 
San Jose, CA, USA) using Analysis of Variance (One-Way for cytocompatibility test and 
Two-Way for all the other tests) and Tukey’s test for multiple comparison (α = 5%).
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3. Results
3.1. Morphological and Chemical Characterizations of the fibres
The PCL- and PCL/GEL-based membranes presented, respectively, a heterogeneous (from 
93 to 2,223 nm) and homogeneous (from 56 to 1,184 nm) fibre diameter distribution (Figure 
1a). The presence of gelatine produced thicker fibres compared to those gelatine-free, 
although only in groups containing none or low content (5 wt.%) of ZnO. The incorporation 
of higher amounts of ZnO (higher than 15 wt.%) resulted in rough fibres with distinct shape 
(e.g., swollen areas) and morphology, although the PCL membranes were more negatively 
affected than those constituted of gelatine (Figure 2). As shown in the EDS analysis (Figure 
1b), ZnO nanoparticles were successfully incorporated into the membranes. The 
nanoparticles differed in shape, although most of them were rod-like and nano-sized (i.e. 
below 100 nm, with an average size of 65 nm) (Figure 3). While the neat fibres were 
visually smooth (Figure 4a), the nanocomposite fibres presented some swollen areas and 
several areas embedded with ZnO nanoparticles (Figure 4b). Lastly, the FTIR analysis also 
revealed incorporation of ZnO into the membranes (Figure 5) and gelatine into the PCL/
GEL-based membranes (Figure 5b). The presence of the peak located at 2,357 cm−1 could 
be observed in the ZnO powder and also in the ZnO-incorporated membranes, but not in the 
neat membranes. FTIR spectra showed some common peaks for all membranes located at 
2,944–2,861 and 1,721 cm−1, which corresponded, respectively, to the presence of the C–H 
bond of saturated carbons and the ester-carbonyl group (−CO stretching) found in PCL [25]. 
In addition, three characteristic peaks confirmed the incorporation of gelatine into the 
PCL/GEL membranes: one located at 3,297 cm−1 (amide-A), another at 1,627 cm−1 (amide-
I), and the last at 1,524 cm−1 (amide-II).
3.2. Contact angle
According to Figure 6, all PCL-based membranes, regardless of the ZnO content (p≥0.056), 
presented a hydrophobic surface (i.e. contact angle higher than 90°), showing poor 
wettability (Zhang et al., 2004). By contrast, PCL/GEL membranes revealed excellent 
wettability/hydrophilicity, with CA ranging from 0° to 42°. The PCL/GEL membranes 
containing 5 and 15 wt.% of ZnO nanoparticles were more hydrophilic than the other 
gelatine-based membranes (p<0.001).
3.3. Mechanical properties
The mechanical performance (e.g. tensile strength, Young’s modulus, and elongation at 
break) of the synthesized membranes is presented in Figure 7. The PCL membranes showed 
a soft nature with moderate flexibility regardless of the storage condition. The incorporation 
of ZnO reduced the mechanical properties, except the elongation at break, which was 
increased with the addition of 30 wt.% of nanoparticles. The presence of gelatine improved 
rigidity of the membranes, but only under dry circumstances (p ≤ 0.002); conversely, storage 
in PBS resulted in a significant decrease in rigidity, although a substantial gain in flexibility 
could be observed: wet specimens of membranes containing 0, 5, 15, and 30 wt.% of ZnO 
displayed, respectively, 3.4, 2.9, 2.7, and 4.3 times higher (p < 0.001) elongation at break 
than the specimens stored dry.
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3.4. Antibacterial activity
Results of the MIC of ZnO nanoparticles are shown in Table 1. From all the concentrations 
tested, the MIC differed according to the bacteria specie: for Pg, the MIC was 2,500 µg/mL, 
whereas it was 5,000 µg/mL for Fn. The increase in ZnO concentration did not result in 
higher inhibition zones against Pg (p ≥ 0.599). By contrast, the inhibition zones were greater 
against Fn with increased content of ZnO (p < 0.001).
Data and representative images from the agar diffusion test are presented in Table 1. All the 
membranes containing different concentrations of ZnO presented antibacterial activity 
against the targeted bacteria, with clear inhibition zones ranging from 6 to 15 mm in 
diameter. The PCL membrane containing 30 wt.% of ZnO exhibited higher (p < 0.001) 
inhibition zone than the low-concentrated group and against both bacterial species. The 
PCL/GEL-based membranes applied against Pg showed similar (p ≥ 0.702) antibacterial 
activity regardless of the concentration of ZnO; however, when applied against Fn, the most 
concentrated group displayed higher antibacterial activity than the others (p < 0.001).
3.5. Cytotoxicity test
As shown in Figure 8, all membranes presented cytocompatibility (i.e. cell viability higher 
than 50%), which was different from the positive control (phenol solution), that was toxic to 
cells, even at low concentrations. Cell viability remained at an optimal level with ZnO 
content up to 15 wt.%; nonetheless, incorporation of a higher amount of nanoparticles 
resulted in a slight toxic effect on the cells, with the PCL/GEL-based membrane producing 
the highest cytotoxic potential.
4. Discussion
In this study, we investigated extensively both the morphology and microstructure of the 
electrospun membranes. According to the SEM micrographs shown in Figure 1a, the 
membranes demonstrated noticeable differences in regard to the morphology of the fibres, 
which was influenced by the polymer system and the content of the ZnO that was 
incorporated. The PCL-based membranes showed a more heterogeneous fibre distribution, 
whereas the PCL/GEL-based membranes presented fibres with a much lower distribution 
range, probably due to the increase in viscosity achieved through gelatine addition, leading 
to a more satisfactory chain entanglement, and thus to the formation of homogeneous fibres 
[37]. Moreover, even though we did not determine the viscosity of the polymer solution or 
the polymer blend, one would consider that the increased viscosity of the gelatine-based 
solutions might also have contributed to the occurrence of thicker fibres compared to those 
gelatine-free, corroborating previous findings [29]. Nonetheless, this effect was observed 
only within the neat fibres and the membrane containing 5 wt.% of ZnO, since the addition 
of higher amounts of ZnO nanoparticles (e.g. 15 and 30 wt.%) progressively reduced fibre 
diameter. One possible explanation is that both gelatine and ZnO nanoparticles can increase 
the electrical conductivity of the polymer solution [38, 39], acting synergistically toward the 
increase in charge density on the surface of the ejected spinning jet, leading to a reduction of 
self-repulsion tension, and consequently to the increase in elongation forces and the 
formation of thinner fibres [25, 40]. Interestingly, the incorporation of ZnO nanoparticles 
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into the PCL/GEL solutions produced smooth fibres, with only some areas displaying 
surface irregularities similar to a bead-like structure. Conversely, the addition of 30 wt.% 
ZnO particles into the PCL-based solution substantially modified the fibres’ morphology, 
which became thicker and rougher compared to the other membranes, probably due to the 
agglomeration of ZnO (Figure 2a) on the surface and inner structure of the fibres [25]. ZnO 
nanoparticles present high surface energy, thus they tend to agglomerate when mixed at 
higher concentrations, forming clusters along the fibre length, and consequently resulting in 
important morphological change. These characteristics may negatively influence cell 
proliferation [41], thus limiting the use of PCL membranes containing high ZnO 
nanoparticles’ content (in this study - 30 wt.%) as GTR/GBR membranes. Nonetheless, the 
presence of gelatine in the PCL solution allowed for the incorporation of a higher ZnO 
amount (i.e. 30 wt.%) without deleterious changes in the morphology and microstructure of 
the obtained membranes.
Though the presence of ZnO nanoparticles can be fairly well noticed in some of the SEM 
micrographs shown in Figures 1a and 2a, EDS (Figure 1b), TEM (Figure 4), and FTIR 
(Figure 5a) analyses confirmed the presence of ZnO trapped within the PCL matrix. Taken 
together, these results confirmed the chemical characteristics of the membranes synthesized 
in the study.
ZnO nanoparticles are not soluble in water. More importantly, considering that PCL is also 
hydrophobic [29, 31], one can expect that the ZnO-incorporated PCL membranes would 
demonstrate poor wettability. Nonetheless, optimal wettability is an important characteristic 
aimed at GTR/GBR membranes [4], since the membranes are placed in direct contact with 
moisture (i.e. fluids present in the periodontal surgical site). Furthermore, several studies 
have demonstrated that hydrophilic scaffolds can display enhanced cell affinity, thus 
allowing improved cell proliferation and wound healing [30, 42]. To that end, gelatine, a 
natural polymer, has been commonly used as an additive to PCL solutions in an attempt to 
increase scaffold hydrophilicity. Although cells can attach and grow in both pure PCL and 
PCL/GEL membranes, cell spreading and migration have been improved within gelatine-
containing membranes [31]. According to Figure 6, all PCL-based membranes presented a 
hydrophobic surface (i.e. contact angle higher than 90°), showing poor wettability [43]. By 
contrast, PCL/GEL membranes revealed excellent wettability/hydrophilicity. An interesting 
finding of the present study was that the PCL/GEL membranes containing 5 and 15 wt.% of 
ZnO nanoparticles were more hydrophilic than the other gelatine-based membranes 
(p<0.001). In fact, 10 s after the water drop (i.e. time set to allow the drop to accommodate 
and interact with the surface [44]), the membranes containing low (5 wt.%) and medium (15 
wt.%) ZnO contents could not maintain a convex shape of the water drops, thus precluding 
the contact angle measurement. This, perhaps, demonstrates that the latter membranes were 
very hydrophilic, and therefore, they can be considered promising for GTR/GBR 
applications. One can also note that the same effect was not seen for the PCL/GEL 
membrane containing ZnO nanoparticles at 30 wt.%, which may possibly be explained by 
the occurrence of van der Waals physical interactions between the nanoparticles and PCL 
polymer chains, as previously suggested [25]. These physical interactions, which may have 
become more intense at higher ZnO contents (e.g. 30 wt.%), could have slightly reduced the 
surface energy of the membrane, thus resulting in lower wettability [43], although still 
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hydrophilic (i.e. contact angle lower than 90°) and comparable to the ZnO-free PCL/GEL 
membrane.
As previously highlighted, despite adequate morphology, microstructure, and wettability, 
GTR/GBR membranes should also present satisfactory mechanical properties to avoid 
membrane collapse into the periodontal defect as a result of compression forces of the soft 
tissues and mastication [4, 7]. Furthermore, GTR/GBR membranes need to display 
appropriate stiffness to withstand cell attachment and proliferation; otherwise, the 
membranes may not be clinically useful [4, 7, 9, 12]. A recent study demonstrated that cell 
viability and proliferation of 3T3 fibroblasts cultured on stiffer membranes were higher than 
on softer ones [45]. Findings from another investigation showed that the increase in elastic 
modulus obtained with the incorporation of alginate in a PCL-based membrane resulted in 
improved cell viability, as well as other important cell activity parameters (e.g. cell 
proliferation, alkaline phosphatase activity, and mineralization ability) [46]. Considering 
these foregoing statements, the mechanical performance (e.g. tensile strength, Young’s 
modulus, and elongation at break) of the synthesized membranes was assessed, under dry 
and wet conditions by uni-axial tensile testing. The results obtained in this study (Figure 7) 
corroborate the findings of some previous studies, which demonstrated that blending 
gelatine with synthetic polymers, such as PCL, can increase the crystallinity [29] and 
mechanical strength of fibres [28–30, 42], although their storage in wet media may produce 
an inverse effect, since gelatine usually does not cross-link to the main polymer chain, 
leading to fast hydrolytic degradation of the system and a reduction of properties [29]. 
Worth mentioning, the use of crosslinking agents (i.e. glutaraldehyde, genipin, etc.) can 
potentially enhance the mechanical properties of these gelatine-containing membranes, since 
crosslinking reactions can be produced, leading to improved mechanical properties and 
degradation resistance [47, 48]. This would be an interesting focus for future studies. With 
regard to ZnO incorporation, an overall analysis of the tensile strength, Young’s modulus, 
and elongation at break of the PCL and PCL/GEL-based membranes, revealed a decrease, 
corroborating with a previous study [25], perhaps with two exceptions: (1) the rigidity of the 
PCL membrane was maintained with the incorporation of 30 wt.% nanoparticles and (2) 
flexibility was significantly increased. This can probably result from microstructure of the 
aforementioned membrane, which showed thicker fibres (Figures 1a and 2a) that withstood 
higher loading during testing and improved flexibility. Nonetheless, and as stated before, 
this membrane would not be ideal for GTR/GBR application, since the microstructure/
morphology of fibres lacked in satisfactory characteristics that resemble the ECM of native 
bone [4].
Another important goal of this study was to demonstrate that ZnO-incorporated membranes 
show antimicrobial activity when compared to their ZnO-free counterparts against common 
periodontopathogens. First, the minimal inhibition concentration (MIC) of ZnO 
nanoparticles was determined using suspensions of ZnO in PBS. According to Table 1, 
against Pg, the MIC was 2,500 µg/mL, whereas against Fn it was 5,000 µg/mL. These 
results are quite different from a previous study, which demonstrated that the MIC of ZnO 
was 250 µg/mL against both Pg and Fn [49]. That concentration, perhaps, was not effective 
in our study, and this may be due to the characteristics of the ZnO nanoparticles used. 
Münchow et al. Page 10
Dent Mater. Author manuscript; available in PMC 2016 September 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
According to recent studies [50, 51], differences in nanoparticle size may play a significant 
role in the antibacterial potential, with smaller particles demonstrating higher surface area, 
and therefore, enhanced inhibitory effects. The study by Vargas-Reus et al. [49] tested 
nanoparticles ranging from 10–50 nm, whereas the nanoparticles used in the present study 
had an average size of 65 nm (Figure 4). Consequently, the surface area of the ZnO particles 
used here was reduced, requiring an increased MIC (Table 1). Interestingly, increased 
concentrations of ZnO did not result in higher inhibition zones against Pg, whereas the 
antibacterial activity of ZnO against Fn was greater at 10,000 µg/mL when compared to the 
5,000 µg/mL concentration. According to these results, the minimum ZnO dose to be tested 
in the present investigation for preparing the PCL- and PCL/GEL-based solutions was 5 wt.
%, which corresponded to the 5,000 µg/mL concentration (i.e. the ZnO concentration that 
was effective against both bacteria species).
Even though the mechanism of action of ZnO is still vaguely understood, it has been 
reported that the nanoparticles can produce reactive oxygen species (ROS), such as hydroxyl 
radicals, super oxides, and hydrogen peroxide, which may penetrate the cell wall and affect 
bacteria integrity [52–54]. In the present study, the antibacterial activity displayed by the 
ZnO-incorporated membranes seemed to be dose-dependent, since the 30 wt.% 
concentration resulted in higher inhibition zones when compared to the less concentrated 
groups (Table 1). Indeed, it is expected that the higher the amount of nanoparticles 
incorporated, the greater the availability of active compound to diffuse into the agar medium 
and effectively inhibit bacterial growth [26]. Notwithstanding, the only exception was seen 
within the PCL/GEL-based membranes applied against Pg, which showed similar 
antibacterial activity regardless of the concentration of ZnO. These findings may suggest 
that gelatine-based materials can interact differently with the bacteria surface, depending on 
the specie evaluated. According to Bhadra et al. [55], amino-based molecules, such as 
gelatine, can interact with the outermost cell membrane of some bacteria by means of amino 
groups (–NH2), enhancing permeability of the latter, and consequently, resulting in its 
destruction/death. This last mechanism might explain the greater antibacterial activity of the 
PCL/GEL-based membranes against Fn, which exhibited inhibition zones ranging from 11 
to 14 mm, and in comparison with Pg (Table 1), whose inhibition zones ranged from 8 to 9 
mm in diameter, only. This is probably due to structural differences [49] between the 
bacteria investigated and possible differences in their intracellular antioxidant content [56]. 
In light of this, the antibacterial potential of ZnO-incorporated membranes should be also 
investigated against different bacteria from those tested here, such as facultative anaerobic 
species, including but not limited to A. actinomycetemcomitans. Notwithstanding, and after 
all, the ZnO-incorporated membranes prepared in this study are promising candidates for 
GTR/GBR applications, showing antibacterial properties that would potentially prevent 
infection and/or recolonization of bacteria at the periodontal site.
Considering that cells need a proper substrate to attach and proliferate in, apart from 
important membrane/scaffold characteristics, such as fibre shape, fibre diameter/distribution, 
pore structure, wettability to facilitate protein adsorption, and cell attachment, GTR/GBR 
ZnO-loaded membranes should invariably be biocompatible. We investigated cell 
compatibility using human dental pulp stem cells, knowing their significant osteogenic 
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differentiation potential [57, 58], key in periodontal bone regeneration. As shown in Figure 
8, all membranes presented cytocompatibility (i.e. cell viability higher than 50%), which 
was different from the positive control (phenol solution), that was toxic to cells, even at low 
concentrations. It is important to note that cell viability remained at an optimal level, even 
with ZnO content up to 15 wt.%, thus confirming the biocompatible nature of the ZnO-
incorporated membranes. Nonetheless, incorporation of a higher amount of nanoparticles 
resulted in a slight toxic effect on the cells, with the PCL/GEL-based membrane producing 
the highest cytotoxic potential. These findings corroborate previous studies, which reported 
that, at low concentration (< 5 wt.%) ZnO is not harmful to cells [23, 25, 59]. 
Notwithstanding, the amount incorporated in the present study was significantly higher 
when compared to these previous studies, but it still did not show strong cytotoxicity, even 
at the 30 wt.% concentration. This may suggest that, perhaps the nanoparticles were 
homogeneously distributed within the fibres, which may, in turn, contribute to a proper and 
safe release of ZnO to the periodontal site.
One should note that the scope of the cell-related work presented in this study was limited. 
Future studies using these novel ZnO-loaded membranes should investigate cell-membrane 
compatibility using other cell types (e.g. periodontal ligament fibroblasts). Furthermore, the 
effects of ZnO should be explored from a molecular standpoint to better understand its role 
on DPSC cell functions and its differentiation before in vivo testing using GTR/GBR 
periodontal defect models.
5. Conclusion
The fabrication of a novel, biocompatible periodontal fibrous membrane with antibacterial 
properties provided by zinc oxide nanoparticles was reported. This electrospun membrane 
holds promise in terms of microstructure/morphology that resembles the extracellular matrix 
of native tissues, wettability characteristics, mechanical integrity, antibacterial activity 
against common periodontopathogens, and cytocompatibility to human dental pulp stem 
cells. It was demonstrated that the incorporation of a low amount of zinc oxide nanoparticles 
can improve the bioactivity of the membranes that may be potentially applied for GTR/GBR 
applications, therefore leading to an enhanced and predictable periodontal regeneration.
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Figure 1. 
(a) Representative SEM micrographs for the PCL- and PCL/GEL-based membranes 
containing different concentrations of ZnO. Insets within the SEM micrographs show the 
mean fibre diameter (dm) and standard deviation (±SD). (b) Representative EDS analysis of 
the PCL nanocomposite membrane containing 15 wt.% of ZnO confirming the presence of 
ZnO nanoparticles within the fibres.
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Figure 2. 
(a) Representative SEM micrograph of the PCL nanocomposite membrane containing 30 wt.
% of ZnO showing the accumulation/agglomeration of ZnO nanoparticles on the surface of 
the fibres. (b–c) TEM images showing the rough surface obtained within the ZnO-
incorporated fibres at different magnifications: (b) 30,000×, and (c) 98,000×.
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Figure 3. 
TEM images showing the overall morphology and size distribution of the ZnO nanoparticles 
used. Image on the left and right illustrate, respectively, magnifications of 120,000× and 
150,000×.
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Figure 4. 
TEM images demonstrating, respectively, the absence and the presence of ZnO 
nanoparticles within the neat PCL fibres (a) and ZnO-incorporated fibres (b). Images on the 
left and right show, respectively, magnifications of 30,000× and 98,000×.
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Figure 5. 
(a–b) FTIR spectra confirming the incorporation of ZnO and gelatin into the PCL- and PCL/
GEL-based membranes.
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Figure 6. 
Images of the contact angle formed between water and the PCL- or PCL/GEL-based 
membranes containing different concentrations of ZnO nanoparticles.
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Figure 7. 
Mechanical characteristics of the PCL- and PCL/GEL-based membranes synthesized in the 
study, under dry (graphs on the left) and wet (graphs on the right) conditions: (a) Tensile 
strength, in MPa; (b) Young’s modulus, in MPa; and (c) Elongation at break, in %.
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Figure 8. 
Cytotoxicity assays results of the PCL- (a) and PCL/GEL-based (b) membranes and cell 
viability means (in %) and standard deviations (±SD) after exposure to the full-concentrated 
(i.e. 100% extract concentration, non-diluted) extracts (c).
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Table 1
Mean (± standard deviation) of the minimal inhibition concentration (MIC) of the zinc oxide (ZnO) 
nanoparticles and antibacterial activity (inhibition halos, in mm) of the prepared electrospun membranes 
against Porphyromonas gingivalis (Pg) and Fusobacterium nucleatum (Fn).
Bacteria CHX (control)
MIC, in µg/mL
2,500 5,000 10,000
Pg A
 11.7 (±0.6) a A 8.3 (±1.2) b A 9.0 (±1.0) b A 8.0 (±0.6) b
Fn A
 10.3 (±0.6) a B 0.0 c B 5.3 (±0.6) b A 9.3 (±1.2) a
ZnO content
(wt.%)
Pg Fn
PCL PCL/GEL PCL PCL/GEL
0 C
 0.0 a C 0.0 a D 0.0 a C 0.0 a
5 B
 6.3 (±0.6) b B 7.7 (±0.6) a C 6.7 (±1.2) b B 11.3 (±0.6) a
15 AB
 9.0 (±1.0) a B 8.3 (±0.6) a BC 9.0 (±1.7) b B 11.7 (±0.6) a
30 A
 11.7 (±2.9) a B 8.3 (±0.6) b A 14.3 (±0.6) a A 13.7 (±0.6) a
CHX (control) AB
 10.0 (±1.0) a A 11.0 (±1.0) a B 9.7 (±0.6) b AB 12.3 (±0.6) a
Distinct uppercase letters in a same column and lowercase letters in a same row indicate statistically significant differences among groups tested (p 
< 0.05).
CHX: chlorhexidine; PCL: Poly(ε-caprolactone); PCL/GEL: mixture of PCL and gelatin (50:50 ratio, w/w).
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